2007 Drugs Pharmacy 
The Pharma Data
DECEMBER 17, 2020
Doctor Johnson has had an inspiring career that encompasses several aspects of the pharmacy industry. She assists both patients and physicians in completing this revolutionary gene test that determines if a patient is on the right drug, at the right dose, for their specific DNA. In the future, Dr.
The Pharma Data
SEPTEMBER 24, 2020
Gilead has agreed to pay $97 million to resolve claims from the US Government that it used an independent charity to pay illegal kickbacks to cover Medicare patients’ upfront costs for its drug Letairis. . This allowed Gilead to boost their revenue from June 2007 to December 2010, which violated the federal False Claims Act.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Agency IQ
SEPTEMBER 15, 2023
FDA’s nonprescription advisors find no efficacy for phenylephrine This week, FDA’s Nonprescription Drugs Advisory Committee (NDAC) voted unanimously that current scientific data do not support the efficacy of oral phenylephrine as a nasal decongestant, aligning with FDA analysis — and re-analysis — of data.
Agency IQ
NOVEMBER 27, 2023
The changes, which should take effect in mid-2024, should result in drug ads with fewer distracting elements and more emphasis on the major risks of the drug. These requirements are further established under 21 CFR 202.1 , which outline FDA’s expectations for prescription drug advertising.
National Institute on Drug Abuse: Nora's Blog
NOVEMBER 25, 2024
Contrary to worries that syringe services programs (SSPs) will encourage or promote drug use, evidence shows that they more often do the opposite, linking people with addiction to effective treatment and even helping prevent overdose deaths. The common belief that SSPs encourage more drug use is contradicted by the data.
Advarra
DECEMBER 14, 2022
Effective as of 2007, Medicare has offered coverage for routine costs in clinical trials. Pharmacy manual. drugs and biologicals. The investigational agent in the trial has an FDA-issued investigational new drug (IND) approval and associated six-digit number. The study is not intended to promote or commercialize the drug.
The Pharma Data
NOVEMBER 25, 2020
The interim final ruling on most-favored-nation status for drug prices is expected to be published on November 27 th in the Federal Register by the Centers for Medicare & Medicaid Services (CMS) at the Department of Health and Huma Services (HHS). Specifically, one study of 27 drugs found the U.S. CMS maintains otherwise.
Expert insights. Personalized for you.
52 
Let's personalize your content